Nano 101
Chair: Aatish Salvi, Vice President NanoBusiness Alliance

Advanced Materials: Scaling the Business to a Size that Matters

Diagnostics: A Prognosis for Change in the Clinical Value Chain

11 - 12:30 pm
From Nanomaterial Inventions to Products and Businesses–A Global Perspective
Session supported by the Consulate General of Canada in New York

Nanotechnology is primarily the search for the means to utilize size-dependant novel properties of materials to commercial advantage, and for human benefit.  This panel session will explore the partnering and financing aspects of this enterprise and illustrate with global successes across borders. 

Tools: Seeing New Models and Markets for Growth

Luncheon Keynote and Exhibits
Dr. Uma Chowdhry, CSTO, DuPont

Back to Top

Track 1:

Closing Keynote
Dr. Hans Stork, CTO, Texas Instruments

Back to Top

Medicine Investing Forum
Chair: Aatish Salvi

Bob Gregg, Executive VP,
FEI Company

NASDAQ Luncheon Keynote Panel: Exit Strategies in Public Markets

The panel will cover the issues and practices that companies need to consider to keep themselves viable for a public offering. Topics will include a discussion on how to determine if your company should begin considering the public markets, what practices early and medium stage companies can adopt to keep their options open for a public exit and how late-stage companies can best manage the costs and process challenges associated with a public exit.

France: Nanotech Advances, Collaborative R&D Programs and Company Presentations

Conference and business exchange to facilitate the exploration of commercial and research relationships between US and French companies and to outline advances in nanotechnology in France, sponsored by: The Invest in France Agency; AEPI - its regional partner from Grenoble; UbiFrance - the French agency for international business development; leading French nanotech companies (including SOITEC), and other research institutions and centers of excellence (including MINATEC).